Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms

View Full Size

Download

Thumbnail GIF, 120x30, 1.6 KB
Preview JPEG, 144x36, 2.0 KB
Small JPEG, 227x57, 2.5 KB
Full Size JPEG, 227x57, 7.6 KB

Smart Multimedia Gallery

U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)

View and Share Photo

Download Small
Download Full Size

http://www.businesswire.com/multimedia/home/20080415006615/en/1606695/Alcons-PATANASE-Nasal-Spray-Approved-FDA-Treatment

Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark

All News | News with Multimedia > News Release: Alcon's PATANASE(R) Nasal Spray Approved by FDA...

Search News:

Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms

Download

Smart Multimedia Gallery

View and Share Photo

Share

More Business Wire sites

About Us

News on BusinessWire.com

Follow Us on Twitter

Like Us on Facebook